NM_000660.7:c.292G>A
Variant summary
The NM_000660.7(TGFB1):c.292G>A (p.Glu98Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene TGFB1 is a tumor suppressor gene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The gene TGFB1 is a known oncogene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The gene TGFB1 is a cancer driver gene (CancerMine: 2 TSG, 9 oncogene, 5 driver citations). The variant allele was found at a cumulative frequency of 0.00000372 (AC=6) in the gnomAD database across 1,613,156 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.E98Q: Uncertain_significance (ClinVar VariationId 3020729, 1 star) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.).
Frequency
Consequence
NM_000660.7 missense
Scores
Clinical Significance
Conservation
Publications
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Camurati-Engelmann disease type 1Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000005 — very rare (O3 supporting [+1]) | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 9 pathogenic, 3 benign (OR vs. background: 13.6).; ±8 AA neighbourhood: 0 pathogenic, 0 benign; Variant does not impact splicing — splice-hotspot path not applicable | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000660.7. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TGFB1 | MANE Select | c.292G>A p.Glu98Lys | missense | Exon 1 of 7 | Prot: NP_000651.3 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TGFB1 | TSL:1MANE Select | c.292G>A p.Glu98Lys | missense | Exon 1 of 7 | Prot: ENSP00000221930.4 UniProt: | |
TMEM91 | TSL:1 | c.-30+1551C>T | intron | Intron 1 of 2 | Prot: ENSP00000441900.1 UniProt: | |
TMEM91 | c.-420C>T | 5_prime_UTR_premature_start_codon_gain | Exon 1 of 4 | Prot: ENSP00000636343.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000131 | AC:2 | Hom:0 | AN:152128 | Cov:31 |
GnomAD2 exomes | AF: 0.00000405 | AC:1 | AN:247200 | ||
GnomAD4 exome | AF: 0.00000274 | AC:4 | Hom:0 | AN:1461028 | Cov:32 |
GnomAD4 genome | AF: 0.0000131 | AC:2 | Hom:0 | AN:152128 | Cov:31 |
TOPMed (Bravo) | AF: 0.0000151 | AC:4 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000469 | AC:1 | Hom:0 | AN:21310 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 22 | |
AlphaMissense | Benign | 0.13 | |
BayesDel_addAF | Benign | -0.053 | T |
BayesDel_noAF | Benign | -0.31 | |
CADD | Benign | 21 | |
DANN | Uncertain | 0.99 | |
Eigen | Benign | -0.68 | |
Eigen_PC | Benign | -0.71 | |
FATHMM_MKL | Benign | 0.30 | N |
FuncVEP CTI | Benign | 0.024 | |
GPN-Star LLR | N/A | -7.7 | |
GPN-Star score | N/A | 7.7 | |
LIST_S2 | Uncertain | 0.90 | D |
M_CAP | Benign | 0.046 | D |
MetaRNN | Benign | 0.11 | T |
MetaSVM | Benign | -0.97 | T |
Mutation Taster | N/A | 89/11 | polymorphism |
PhyloP100 | Benign | 0.54 | |
popEVE | Benign | -3.2 | |
PrimateAI | Uncertain | 0.68 | T |
PromoterAI | N/A | 0.040 | Neutral |
PROVEAN | Benign | -0.94 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Benign | 0.18 | |
Sift | Benign | 0.099 | T |
Sift4G | Benign | 0.30 | T |
VESM-3B | Benign | -7.5 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.